BLGO (BioLargo) NonCurrent Deferred Liabilities: $0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is BioLargo NonCurrent Deferred Liabilities?

BioLargo BLGO +1.50% NonCurrent Deferred Liabilities is $0.00 Mil as of Jun. 2026. The stock has 8 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

BioLargo's non-current deferred liabilities for the quarter that ended in Jun. 2026 was $0.00 Mil.

BioLargo NonCurrent Deferred Liabilities Related Terms

BioLargo NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for BioLargo's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioLargo NonCurrent Deferred Liabilities Chart

BioLargo Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BioLargo Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
What does a NonCurrent Deferred Liabilities of $0.00 Mil mean?
BioLargo (BLGO) has a NonCurrent Deferred Liabilities of $0.00 Mil as of Jun. 2026. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on BioLargo and its competitors.
Is BioLargo's NonCurrent Deferred Liabilities too high?
BioLargo's current NonCurrent Deferred Liabilities is $0.00 Mil.
How does BioLargo's NonCurrent Deferred Liabilities compare to BIOF and LOOP?
BioLargo's NonCurrent Deferred Liabilities of $0.00 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Chemicals company?
A good NonCurrent Deferred Liabilities depends on the Chemicals industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on BioLargo and its competitors. BioLargo's current NonCurrent Deferred Liabilities is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioLargo stock overvalued right now?
Based on GuruFocus' analysis, BioLargo (BLGO) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.07, compared to a current price of $0.09 — trading 35.6% above its estimated fair value. The current NonCurrent Deferred Liabilities is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For BioLargo (BLGO), the current NonCurrent Deferred Liabilities is $0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioLargo Business Description

Address 14921 Chestnut Street, Westminster, CA, USA, 92683
BioLargo Inc invents, develops, and commercializes platform technologies to solve challenging environmental problems like PFAS contamination, water and wastewater treatment, industrial odor, VOC control, air quality control, and infection control. The company has six segments: ONM Environmental; Clyra Medical; BLEST; BETI; BEST; and BioLargo Canada. ONM Environmental, which sells odor and volatile organic control products and services, located in Westminster, California, derives the maximum revenue.